Pınar İbrahim E, Ozkocaman V. Efficacy and safety outcomes of single-agent ibrutinib therapy in chronic lymphocytic leukemia and relapsed/refractory mantle-cell lymphoma. Eur Res J [Internet]. 2023 Nov. 3 [cited 2026 Apr. 5];9(6):1483-92. Available from: https://eurj.org.tr/article/view/874